<DOC>
	<DOCNO>NCT01964014</DOCNO>
	<brief_summary>The objective study assess efficacy safety Immunosuppressant Therapy Barrier Scale ( ITBS ) daily immunosuppressant maintenance therapy patient kidney transplantation earlier .</brief_summary>
	<brief_title>Once-a-day Immunosuppression ( CISECON_a_day )</brief_title>
	<detailed_description>This 6-month , single-arm , multi-center , open-label , continuous cohort study . 160 subject kidney transplantation least 3 month earlier participate study . All enrolled subject discontinue exist Tacrolimus preparation 6 month enrollment convert Extended Release Tacrolimus biologically equivalent dose . They also discontinue enteric-coated mycophenolate sdium mycophenolate sodium treat Sirolimus observe .</detailed_description>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Men woman age 20 65 kidney transplantation least 3 month ago . Recipients kidney transplantation decease / cadaveric donor , nonheart beat cadaveric donor / organ donor cardiac death , nonblood relate blood relate live donor . Patients treat Tacrolimus Extended Release Tacrolimus exist immunosuppressant maintenance therapy . Able willing give inform consent study participation , sign informed consent form accord appropriate procedure , capable participate study make visit accord study plan . HIV , HBsAg , antiHCV test positive patient receive kidney transplantation HIV , HBsAg , antiHCV test positive donor . History severe allergy hypersensitivity drug use study drug similar chemical structure require acute ( within past 4 week ) chronic treatment . Having receive investigational product within 30 day prior enrollment study . Women childbearing potential plan become pregnant , pregnant and/or lactate woman , woman intend use effective contraceptive . Having uncontrolled disease medical condition require continuous treatment . History alcohol drug addiction within past 3 month incapable appropriate communication due reason mental illness . Absolute neutrophil count &lt; 1,500/mm3 leukocyte count &lt; 2,500/mm3 platelet count &lt; 75,000/mm3 screen severe metabolic disorder ( include functional disorder ) . Having experience follow condition within past 1 month : Serum creatinine &gt; 2.0 mg/dl twice . 24 hr urine proteinâ‰¥750 mg/day Diagnosed treat rejection reaction infection hospitalize due medical reason .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword />
</DOC>